Gapping up
In reaction to earnings/guidance:
- PI +16.5%, NOW +14.3%, TDOC +11.6%, GSHD +9.5%, HZO +7.5%, ETD +7.4%, OII +6.9%, SHOP +6.6%, PTEN +6.3%, FLEX +6.3%, PPC +6.2%, BUD +6.2%, UCTT +6% (also authorizes new $150 mln share repurchase program), ALSN +5.7%, COUR +5.3%, SHEL +5.2%, CAT +5.2%, HON +5.1%, PGRE +5%, VMI +5%, MMSI +5%, PLXS +4.7%, OMF +4.4%, CCJ +4.1%, LUV +4.1%, ARES +3.9%, CARR +3.3%, BHE +3.2%, MCD +3%, MOH +2.9%, AZPN +2.9%, TPH +2.8%, ORLY +2.4%, MRK +2.2%, ARCH +2.2%, MUSA +2.1%, NLY +1.8%, ABEV +1.8%, AIT +1.8%, PDS +1.5%, DAN +1.5%, VC +1.4%, AR +1.2%, ENSG +1.2%, BFH +1.2%, AEM +1.1%, TTE +1.1%, ACMR +1.1%, BWA +1.1%, CMS +1.1%, AM +1%, LYG +1%, LPG +1%
Other news:
- GENI +5% (expands partnership with Football DataCo for Premier League)
- AMSF +5% (declares special cash dividend of $4/sh)
- VRAY +2.3% (MIRAGE Phase III Randomized Controlled Trial Demonstrates Superiority of MRIdian MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer)
- MRK +2.2% (names new chairman)
- JXN +2.1% (expands relationship with Halo Investing)
- MRO +1.6% (increases dividend)
- AWK +1.6% (acquires City of Blue Grass wastewater system)
Analyst comments:
- AGNC +2.3% (upgraded to Overweight from Equal Weight at Barclays)
- NLY +1.8% (upgraded to Overweight from Equal Weight at Barclays)